Delivery Order SPE2DB22D1106-SPE2DB24FEHC1
Award Date 3/27/24
Potential Completion Date 3/28/24
Potential Value $18K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,828.64 firm fixed price delivery order is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a specialty pharmaceutical product. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary contract vehicle for...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of VIVITROL 380 MG VIAL-DILUENTS. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $3,568.00. The contract has an ultimate completion date of April 18, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Delivery Order valued at $2,418.54. The contract has an ultimate completion date of April 23, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, particularly the Department of...
- This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS. The $2,837.76 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA), a defense agency, on December 20, 2024, with a completion date of December 23, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS. The firm fixed price delivery order has a potential value of $1,828.64 and a completion date of March 7, 2024. Amerisourcebergen Drug Corp, as the prime contractor, holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,001.17 firm fixed-price delivery order is for VIVITROL 380 MG VIAL-DILUENTS and has a completion date of January 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies in...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $10,795.98, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a specialty medication. The contract is a Firm Fixed Price Delivery Order, with a completion date of September 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) is for the delivery of VIVITROL 380 MG VIAL-DILUENTS medical supplies. The contract, valued at $12,296.96, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical under Delivery Order SPE2DX15D1053|SPE2DX25F6FQB. This is a firm fixed-price contract with a completion date of January 2, 2025. The contract is not set aside for any specific business type. Amerisourcebergen, a major pharmaceutical...
- This contract award to Amerisourcebergen Drug Corp is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a pharmaceutical product. The contract has a ceiling value of $11,886.03 and is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 380 mg VIVITROL vials and diluents. The $2,798.10 contract has a completion date of February 1, 2024. AmerisourceBergen Drug Corp, a for-profit organization, serves as the prime contractor on this delivery order, which is not associated with any set-aside program. This award is part of a larger...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEHC1Delivery Order
This contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $18,286.20 firm fixed price delivery order has a period of performance through March 28, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceuticals and medical supplies to military treatment programs and facilities. This contract award does not have a set-aside designation.
Generated 6/26/24, 9:44 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.3k | 3/27/24 |